Tag:
eribulin
Latest Headlines
Latest Headlines
Eisai gains cancer drug approval as it takes a big patent hit
Japan's Eisai has picked up a key regulatory win at the FDA, gaining approval to start selling a new breast cancer drug as a third-line therapy just as its big Alzheimer's drug--Aricept--rolls off
BMS, Pfizer cancer drugs take starring roles at ASCO
Bristol-Myers Squibb's ipilimumab took the center ring at ASCO over the weekend, earning star billing for its promising data on melanoma. In a small trial, patients taking the drug lived a median of
Eisai pursues blockbuster approvals for breast cancer drug
More than two years after it had originally planned, Eisai has filed for FDA approval of the experimental breast cancer drug eribulin, marking the first new drug application filed by Eisai in the
